Epithelial ovarian cancer: Disease etiology, treatment, detection, and investigational gene, metabolite, and protein biomarkers

Taufika Islam Williams, Kristina L. Toups, Diana A. Saggese, Kimberly R. Kalli, William Arthur Cliby, David C. Muddiman

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

Cancer research in recent years has immensely benefited from the development of novel technologies that enable scientists to perform detailed investigations of genomes, transcriptomes, proteomes, and metabolomes. This has invariably furthered knowledge of tumorigenesis and etiology of cancer. The resulting information can, in the foreseeable future, effect a significant change in the pace of cancer research, thereby producing improvements in patient care. Ovarian cancer in particular has received the interest of the scientific community, being the most frequent cause of death from gynecological cancers, characterized by few early symptoms, diagnosis at an advanced stage, as well as poor prognosis. Ovarian cancer is a malignancy in which normal ovarian cells begin to grow in an uncontrolled, abnormal manner and produce tumors in one or both ovaries. Epithelial cancers, the most common ovarian cancers (>80%), develop from cells lining the ovarian surface. Most ovarian cancer research is primarily focused on the early detection and treatment of epithelial ovarian cancer, the more common ovarian malignancy. This review offers an introduction to ovarian cancer, with particular emphasis on human epithelial ovarian cancer. Current methods of detection and therapy are discussed. A survey of promising new protein, gene, and metabolite biomarkers on the horizon is provided. Future prospects for improved diagnosis are offered.

Original languageEnglish (US)
Pages (from-to)2936-2962
Number of pages27
JournalJournal of Proteome Research
Volume6
Issue number8
DOIs
StatePublished - Aug 2007

Fingerprint

Ovarian Diseases
Investigational Therapies
Biomarkers
Metabolites
Genes
Ovarian Neoplasms
Neoplasms
Proteins
Proteome
Linings
Tumors
Research
Metabolome
Ovarian epithelial cancer
Transcriptome
Early Diagnosis
Cause of Death
Ovary
Patient Care
Carcinogenesis

Keywords

  • Biomarkers
  • Detection
  • Epithelial ovarian cancer
  • Mass spectrometry
  • Proteomics
  • Treatments

ASJC Scopus subject areas

  • Genetics
  • Biotechnology
  • Biochemistry

Cite this

Epithelial ovarian cancer : Disease etiology, treatment, detection, and investigational gene, metabolite, and protein biomarkers. / Williams, Taufika Islam; Toups, Kristina L.; Saggese, Diana A.; Kalli, Kimberly R.; Cliby, William Arthur; Muddiman, David C.

In: Journal of Proteome Research, Vol. 6, No. 8, 08.2007, p. 2936-2962.

Research output: Contribution to journalArticle

Williams, Taufika Islam ; Toups, Kristina L. ; Saggese, Diana A. ; Kalli, Kimberly R. ; Cliby, William Arthur ; Muddiman, David C. / Epithelial ovarian cancer : Disease etiology, treatment, detection, and investigational gene, metabolite, and protein biomarkers. In: Journal of Proteome Research. 2007 ; Vol. 6, No. 8. pp. 2936-2962.
@article{e2c4c741805d47ab8b77b9ef3180f29b,
title = "Epithelial ovarian cancer: Disease etiology, treatment, detection, and investigational gene, metabolite, and protein biomarkers",
abstract = "Cancer research in recent years has immensely benefited from the development of novel technologies that enable scientists to perform detailed investigations of genomes, transcriptomes, proteomes, and metabolomes. This has invariably furthered knowledge of tumorigenesis and etiology of cancer. The resulting information can, in the foreseeable future, effect a significant change in the pace of cancer research, thereby producing improvements in patient care. Ovarian cancer in particular has received the interest of the scientific community, being the most frequent cause of death from gynecological cancers, characterized by few early symptoms, diagnosis at an advanced stage, as well as poor prognosis. Ovarian cancer is a malignancy in which normal ovarian cells begin to grow in an uncontrolled, abnormal manner and produce tumors in one or both ovaries. Epithelial cancers, the most common ovarian cancers (>80{\%}), develop from cells lining the ovarian surface. Most ovarian cancer research is primarily focused on the early detection and treatment of epithelial ovarian cancer, the more common ovarian malignancy. This review offers an introduction to ovarian cancer, with particular emphasis on human epithelial ovarian cancer. Current methods of detection and therapy are discussed. A survey of promising new protein, gene, and metabolite biomarkers on the horizon is provided. Future prospects for improved diagnosis are offered.",
keywords = "Biomarkers, Detection, Epithelial ovarian cancer, Mass spectrometry, Proteomics, Treatments",
author = "Williams, {Taufika Islam} and Toups, {Kristina L.} and Saggese, {Diana A.} and Kalli, {Kimberly R.} and Cliby, {William Arthur} and Muddiman, {David C.}",
year = "2007",
month = "8",
doi = "10.1021/pr070041v",
language = "English (US)",
volume = "6",
pages = "2936--2962",
journal = "Journal of Proteome Research",
issn = "1535-3893",
publisher = "American Chemical Society",
number = "8",

}

TY - JOUR

T1 - Epithelial ovarian cancer

T2 - Disease etiology, treatment, detection, and investigational gene, metabolite, and protein biomarkers

AU - Williams, Taufika Islam

AU - Toups, Kristina L.

AU - Saggese, Diana A.

AU - Kalli, Kimberly R.

AU - Cliby, William Arthur

AU - Muddiman, David C.

PY - 2007/8

Y1 - 2007/8

N2 - Cancer research in recent years has immensely benefited from the development of novel technologies that enable scientists to perform detailed investigations of genomes, transcriptomes, proteomes, and metabolomes. This has invariably furthered knowledge of tumorigenesis and etiology of cancer. The resulting information can, in the foreseeable future, effect a significant change in the pace of cancer research, thereby producing improvements in patient care. Ovarian cancer in particular has received the interest of the scientific community, being the most frequent cause of death from gynecological cancers, characterized by few early symptoms, diagnosis at an advanced stage, as well as poor prognosis. Ovarian cancer is a malignancy in which normal ovarian cells begin to grow in an uncontrolled, abnormal manner and produce tumors in one or both ovaries. Epithelial cancers, the most common ovarian cancers (>80%), develop from cells lining the ovarian surface. Most ovarian cancer research is primarily focused on the early detection and treatment of epithelial ovarian cancer, the more common ovarian malignancy. This review offers an introduction to ovarian cancer, with particular emphasis on human epithelial ovarian cancer. Current methods of detection and therapy are discussed. A survey of promising new protein, gene, and metabolite biomarkers on the horizon is provided. Future prospects for improved diagnosis are offered.

AB - Cancer research in recent years has immensely benefited from the development of novel technologies that enable scientists to perform detailed investigations of genomes, transcriptomes, proteomes, and metabolomes. This has invariably furthered knowledge of tumorigenesis and etiology of cancer. The resulting information can, in the foreseeable future, effect a significant change in the pace of cancer research, thereby producing improvements in patient care. Ovarian cancer in particular has received the interest of the scientific community, being the most frequent cause of death from gynecological cancers, characterized by few early symptoms, diagnosis at an advanced stage, as well as poor prognosis. Ovarian cancer is a malignancy in which normal ovarian cells begin to grow in an uncontrolled, abnormal manner and produce tumors in one or both ovaries. Epithelial cancers, the most common ovarian cancers (>80%), develop from cells lining the ovarian surface. Most ovarian cancer research is primarily focused on the early detection and treatment of epithelial ovarian cancer, the more common ovarian malignancy. This review offers an introduction to ovarian cancer, with particular emphasis on human epithelial ovarian cancer. Current methods of detection and therapy are discussed. A survey of promising new protein, gene, and metabolite biomarkers on the horizon is provided. Future prospects for improved diagnosis are offered.

KW - Biomarkers

KW - Detection

KW - Epithelial ovarian cancer

KW - Mass spectrometry

KW - Proteomics

KW - Treatments

UR - http://www.scopus.com/inward/record.url?scp=34548173778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548173778&partnerID=8YFLogxK

U2 - 10.1021/pr070041v

DO - 10.1021/pr070041v

M3 - Article

C2 - 17583933

AN - SCOPUS:34548173778

VL - 6

SP - 2936

EP - 2962

JO - Journal of Proteome Research

JF - Journal of Proteome Research

SN - 1535-3893

IS - 8

ER -